Brit J. Hart

15.6k total citations · 2 hit papers
8 papers, 1.1k citations indexed

About

Brit J. Hart is a scholar working on Infectious Diseases, Immunology and Animal Science and Zoology. According to data from OpenAlex, Brit J. Hart has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Immunology and 2 papers in Animal Science and Zoology. Recurrent topics in Brit J. Hart's work include SARS-CoV-2 and COVID-19 Research (5 papers), Viral Infections and Outbreaks Research (4 papers) and Hepatitis B Virus Studies (2 papers). Brit J. Hart is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Viral Infections and Outbreaks Research (4 papers) and Hepatitis B Virus Studies (2 papers). Brit J. Hart collaborates with scholars based in United States. Brit J. Hart's co-authors include Peter B. Jahrling, Julie Dyall, Lisa E. Hensley, Michael R. Holbrook, Matthew B. Frieman, Gene G. Olinger, Jason Kindrachuk, Reed F. Johnson, Christopher M. Coleman and Pamela J. Glass and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Brit J. Hart

8 papers receiving 1.1k citations

Hit Papers

Repurposing of Clinically... 2014 2026 2018 2022 2014 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
    2014 475 citations Julie Dyall, Christopher M. Coleman et al. Antimicrobial Agents and Chemotherapy profile →
  2. Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis
    2014 307 citations Jason Kindrachuk, Brit J. Hart et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brit J. Hart United States 7 753 254 181 137 128 8 1.1k
Melissa M. Coughlin United States 12 768 1.0× 276 1.1× 242 1.3× 141 1.0× 62 0.5× 27 1.2k
Dewald Schoeman South Africa 6 1.0k 1.4× 345 1.4× 153 0.8× 78 0.6× 147 1.1× 7 1.4k
Prathanporn Kaewpreedee Hong Kong 3 1.2k 1.6× 182 0.7× 145 0.8× 120 0.9× 255 2.0× 5 1.5k
Xianyue Wang China 9 1.3k 1.7× 442 1.7× 158 0.9× 105 0.8× 213 1.7× 13 1.9k
Ana Shulla United States 8 581 0.8× 314 1.2× 82 0.5× 147 1.1× 86 0.7× 8 1.0k
Lijun Quan China 6 1.3k 1.7× 404 1.6× 196 1.1× 71 0.5× 210 1.6× 10 1.7k
Yanchen Zhou United States 15 584 0.8× 224 0.9× 105 0.6× 135 1.0× 97 0.8× 29 1.3k
Coralie Valle France 6 1.0k 1.4× 229 0.9× 103 0.6× 113 0.8× 180 1.4× 9 1.3k
Taylor Heald‐Sargent United States 10 826 1.1× 152 0.6× 77 0.4× 175 1.3× 120 0.9× 20 1.1k
Natacha S. Ogando Netherlands 12 778 1.0× 403 1.6× 91 0.5× 96 0.7× 62 0.5× 22 1.1k

Countries citing papers authored by Brit J. Hart

Since Specialization
Citations

This map shows the geographic impact of Brit J. Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brit J. Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brit J. Hart more than expected).

Fields of papers citing papers by Brit J. Hart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brit J. Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brit J. Hart. The network helps show where Brit J. Hart may publish in the future.

Co-authorship network of co-authors of Brit J. Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Brit J. Hart. A scholar is included among the top collaborators of Brit J. Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brit J. Hart. Brit J. Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dyall, Julie, Joshua C. Johnson, Brit J. Hart, et al.. (2018). In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus. The Journal of Infectious Diseases. 218(suppl_5). S592–S596. 13 indexed citations
2.
Postnikova, Elena, Yu Cong, Lisa Evans DeWald, et al.. (2018). Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs. PLoS ONE. 13(3). e0194880–e0194880. 32 indexed citations
3.
Cong, Yu, Brit J. Hart, Robin Gross, et al.. (2018). MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. PLoS ONE. 13(3). e0194868–e0194868. 80 indexed citations
4.
Dyall, Julie, Brit J. Hart, Elena Postnikova, et al.. (2017). Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based Assays. The Journal of Infectious Diseases. 215(9). 1416–1420. 11 indexed citations
5.
Kindrachuk, Jason, Brit J. Hart, Steven Mazur, et al.. (2014). Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis. Antimicrobial Agents and Chemotherapy. 59(2). 1088–1099. 307 indexed citations breakdown →
6.
Dyall, Julie, Christopher M. Coleman, Brit J. Hart, et al.. (2014). Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection. Antimicrobial Agents and Chemotherapy. 58(8). 4885–4893. 475 indexed citations breakdown →
7.
Hart, Brit J., Julie Dyall, Elena Postnikova, et al.. (2013). Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. Journal of General Virology. 95(3). 571–577. 161 indexed citations
8.
Zhu, Jie, Brit J. Hart, Shaojing Chang, et al.. (2009). Identification of PTCH1 requirement for influenza virus using random homozygous gene perturbation.. PubMed. 1(3). 259–66. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa M. Coughlin Breakdown of academic impact, for papers by Dewald Schoeman Breakdown of academic impact, for papers by Prathanporn Kaewpreedee Breakdown of academic impact, for papers by Xianyue Wang Breakdown of academic impact, for papers by Ana Shulla Breakdown of academic impact, for papers by Lijun Quan Breakdown of academic impact, for papers by Yanchen Zhou Breakdown of academic impact, for papers by Coralie Valle Breakdown of academic impact, for papers by Taylor Heald‐Sargent Breakdown of academic impact, for papers by Natacha S. Ogando
Rankless by CCL
2026